Back to Executive Team

Amy B. Sullivan

SVP, Corporate Affairs

Amy Sullivan joined Keryx in April 2014 and serves as our senior vice president of corporate affairs. In this role, Ms. Sullivan directs the company’s investor relations, corporate communications, internal communications and advocacy programs.

Ms. Sullivan brings to Keryx more than two decades of broad corporate communications and investor relations experience in the biotech and healthcare industries, including a substantial background in creating and managing communications strategies for both development stage and commercial companies. She has also been successful in helping organizations position and differentiate themselves in competitive environments.

Prior to joining Keryx, Ms. Sullivan spent five years at AMAG Pharmaceuticals where she was vice president of investor relations and corporate communications leading the company’s investor relations, public relations, and employee communications activities. She also held investor relations and communications leadership roles at Idenix Pharmaceuticals, Genencor International, Perkin Elmer and Thermo Fisher. Ms. Sullivan holds a Masters in Business Administration degree from Bentley University and a Bachelor of Science degree from Salem State University.

You are leaving

You are leaving, a website of Keryx Biopharmaceuticals, Inc. Keryx does not review or control the content of non-Keryx websites, and this hyperlink does not constitute an endorsement by Keryx of the site’s content. Keryx’s privacy procedures do not apply to the owners of a non-Keryx website.